Medicare Enrolled

Dr. Monica Schwarcz, MD

Endocrinology · Valhalla, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
95 GRASSLANDS RD, Valhalla, NY 10595
9145944385
In practice since 2007 (18 years)
NPI: 1184818049 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Schwarcz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schwarcz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Schwarcz

Dr. Monica Schwarcz is an endocrinology specialist in Valhalla, NY, with 18 years of NPI registration. Based on federal Medicare data, Dr. Schwarcz performed 4,053 Medicare services across 751 unique beneficiaries.

Between the years covered by Open Payments, Dr. Schwarcz received a total of $3,629 from 36 pharmaceutical and/or device companies across 173 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Schwarcz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 17% volume in NY $3,629 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,053
Medicare services
Top 17% in NY for endocrinology
751
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~225 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 2,940 $18 $50
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
501 $107 $550
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
362 $8 $21
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
72 $3 $25
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
57 $13 $275
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
53 $148 $997
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
31 $31 $200
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
14 $73 $375
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
12 $35 $108
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
11 $72 $176
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,629
Total received (2018-2024)
Avg $518/year across 7 years
Top 32% in NY for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
173
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,629 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$259
2023
$901
2022
$1,238
2021
$568
2020
$239
2019
$379
2018
$45

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$59
Abbott Laboratories
$54
Currax Pharmaceuticals LLC
$53
Mannkind Corporation
$25
Radius Health, Inc.
$20
IBSA Pharma Inc.
$19
Antares Pharma, Inc.
$16
Novo Nordisk Inc
$13
Top 3 companies account for 64.1% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$553
Novo Nordisk Inc
$534
Horizon Therapeutics plc
$398
Lilly USA, LLC
$341
AbbVie Inc.
$253
Amneal Pharmaceuticals LLC
$157
Abbott Laboratories
$147
Mannkind Corporation
$108
Currax Pharmaceuticals LLC
$105
Bayer HealthCare Pharmaceuticals Inc.
$100
Corcept Therapeutics
$89
ABBVIE INC.
$87
Amgen Inc.
$79
Novartis Pharmaceuticals Corporation
$70
MannKind Corporation
$60
Xeris Pharmaceuticals, Inc.
$59
Intra-Sana Laboratories
$54
Eisai Inc.
$45
Radius Health, Inc.
$42
Bayer Healthcare Pharmaceuticals Inc.
$42
Insulet Corporation
$31
PFIZER INC.
$28
AbbVie, Inc.
$24
IDORSIA PHARMACEUTICALS US INC
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
IBSA Pharma Inc.
$19
RECORDATI_RARE_DISEASES_INC.
$19
EUSA Pharma (US) LLC
$19
Dynavax Technologies Corporation
$18
Evofem Biosciences, Inc.
$18
Sun Pharmaceutical Industries Inc.
$16
Antares Pharma, Inc.
$16
Astellas Pharma US Inc
$16
Merck Sharp & Dohme Corporation
$16
SANOFI-AVENTIS U.S. LLC
$14
GRT US Holding, Inc.
$12
Top 3 companies account for 40.9% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · CONTRAVE · ENTRESTO · EVENITY · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · GARDASIL9 · GVOKE PFS · Heplisav-B · ILUMYA · JARDIANCE · Kerendia · Korlym · Lenvima · MOUNJARO · Omnipod · Ozempic · Phexxi · Prolia · QUVIVIQ · Qutenza · RELTONE 200 MG · SIGNIFOR LAR · SOMAVERT · SYNTHROID · Saxenda · Sylvant · Synthroid · TEPEZZA · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tymlos · UNITHROID · Veozah · Wegovy · XYOSTED
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Valhalla?
Compare endocrinologists in the Valhalla area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
443
Per 100K population
44.4
County median income
$118,411
Nearest hospital
WESTCHESTER MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Schwarcz is a mixed practice specialist, with above-average Medicare volume (top 17% in NY), with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Schwarcz experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Schwarcz performed 2,940 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Schwarcz receive payments from pharmaceutical companies?
Yes. Dr. Schwarcz received a total of $3,629 from 36 companies across 173 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schwarcz's costs compare to other endocrinologists in Valhalla?
Dr. Schwarcz's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schwarcz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →